TY  - JOUR
AU  - Onecha, Esther
AU  - Linares, Maria
AU  - Rapado, Inmaculada
AU  - Ruiz-Heredia, Yanira
AU  - Martinez-Sanchez, Pilar
AU  - Cedena, Teresa
AU  - Pratcorona, Marta
AU  - Oteyza, Jaime Perez
AU  - Herrera, Pilar
AU  - Barragan, Eva
AU  - Montesinos, Pau
AU  - Vela, Jose Antonio Garcia
AU  - Magro, Elena
AU  - Anguita, Eduardo
AU  - Figuera, Angela
AU  - Riaza, Rosalia
AU  - Martinez-Barranco, Pilar
AU  - Sanchez-Vega, Beatriz
AU  - Nomdedeu, Josep
AU  - Gallardo, Miguel
AU  - Martinez-Lopez, Joaquin
AU  - Ayala, Rosa
PY  - 2019
DO  - 10.3324/haematol.2018.194712
SN  - 0390-6078
UR  - http://hdl.handle.net/20.500.12105/7540
AB  - A high proportion of patients with acute myeloid leukemia who achieve minimal residual disease negative status ultimately relapse because a fraction of pathological clones remains undetected by standard methods. We designed and validated a...
LA  - eng
PB  - Fondazione Ferrata Storti
KW  - STEM-CELL TRANSPLANTATION
KW  - PROGNOSTIC RELEVANCE
KW  - FLOW-CYTOMETRY
KW  - GENE-MUTATIONS
KW  - DIAGNOSIS
KW  - AML
KW  - RECOMMENDATIONS
KW  - OUTCOMES
KW  - THERAPY
TI  - A novel deep targeted sequencing method for minimal residual disease monitoring in acute myeloid leukemia
TY  - journal article
ER  -